
Vivani Medical Inc.
Prices are adjusted according to historical splits.

Vitals
- Today's Low:
- $0.95
- Today's High:
- $0.9878
- Open Price:
- $0.963
- 52W Low:
- $0.7536
- 52W High:
- $3.24
- Prev. Close:
- $0.95
- Volume:
- 32584
Company Statistics
- Market Cap.:
- $47.26 million
- Book Value:
- 0.638
- Revenue TTM:
- $0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- $130000
- Profit Margin:
- 0%
- Return on Assets TTM:
- -50.83%
- Return on Equity TTM:
- -135.65%
Company Profile
Vivani Medical Inc. had its IPO on 2014-11-19 under the ticker symbol VANI.
The company operates in the Healthcare sector and Biotechnology industry. Vivani Medical Inc. has a staff strength of 50 employees.
Stock update
Shares of Vivani Medical Inc. opened at $0.96 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.95 - $0.99, and closed at $0.96.
This is a +1.05% increase from the previous day's closing price.
A total volume of 32,584 shares were traded at the close of the day’s session.
In the last one week, shares of Vivani Medical Inc. have increased by +3.23%.
Vivani Medical Inc.'s Key Ratios
Vivani Medical Inc. has a market cap of $47.26 million, indicating a price to book ratio of 1.5904 and a price to sales ratio of 0.
In the last 12-months Vivani Medical Inc.’s revenue was $0 with a gross profit of $130000 and an EBITDA of $-26451000. The EBITDA ratio measures Vivani Medical Inc.'s overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Vivani Medical Inc.’s operating margin was 0% while its return on assets stood at -50.83% with a return of equity of -135.65%.
In Q2, Vivani Medical Inc.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Vivani Medical Inc.’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.38 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vivani Medical Inc.’s profitability.
Vivani Medical Inc. stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -1.8796. Its price to sales ratio in the trailing 12-months stood at 0.
Vivani Medical Inc. stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $59.61 million
- Total Liabilities
- $7.09 million
- Operating Cash Flow
- $-44000.00
- Capital Expenditure
- $44000
- Dividend Payout Ratio
- 0%
Vivani Medical Inc. ended 2023 with $59.61 million in total assets and $0 in total liabilities. Its intangible assets were valued at $59.61 million while shareholder equity stood at $32.39 million.
Vivani Medical Inc. ended 2023 with $0 in deferred long-term liabilities, $7.09 million in other current liabilities, 5000.00 in common stock, $-85630000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $32.49 million and cash and short-term investments were $32.49 million. The company’s total short-term debt was $861,000 while long-term debt stood at $0.
Vivani Medical Inc.’s total current assets stands at $36.22 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $1.99 million and inventory worth $0.
In 2023, Vivani Medical Inc.'s operating cash flow was $-44000.00 while its capital expenditure stood at $44000.
Comparatively, Vivani Medical Inc. paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- $0.96
- 52-Week High
- $3.24
- 52-Week Low
- $0.7536
- Analyst Target Price
- $4
Vivani Medical Inc. stock is currently trading at $0.96 per share. It touched a 52-week high of $3.24 and a 52-week low of $3.24. Analysts tracking the stock have a 12-month average target price of $4.
Its 50-day moving average was $1.14 and 200-day moving average was $1.18 The short ratio stood at 7.8 indicating a short percent outstanding of 0%.
Around 4782.6% of the company’s stock are held by insiders while 847.6% are held by institutions.
Frequently Asked Questions About Vivani Medical Inc.
Similar Industry Stocks (Biotechnology)
Most Active
Top Gainers
Top Losers
About
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.